<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR39">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Domingos</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Duarte</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Saraiva</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Guedes</surname>
    <given-names>RC</given-names>
   </name>
   <name>
    <surname>Moreira</surname>
    <given-names>R</given-names>
   </name>
  </person-group>
  <article-title>Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease</article-title>
  <source>Future Med Chem</source>
  <year>2019</year>
  <volume>11</volume>
  <fpage>1953</fpage>
  <lpage>1977</lpage>
  <?supplied-pmid 31517532?>
  <pub-id pub-id-type="pmid">31517532</pub-id>
 </element-citation>
</ref>
